Humacyte annual return on equity
2022
2023
Humacyte Return on Equity (ROE) Growth & History (HUMA)
Humacyte's return on equity was −169.81% for fiscal 2023.
View full Humacyte company overviewHumacyte annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −169.81% | −159.80 pp |
| 2022 | 2022-12-31 | −10.01% | — |
Humacyte quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −171.63% | +16.21 pp |
| Q1 2026 | 2026-03-31 | −239.18% | — |
| Q2 2025 | 2025-06-30 | −187.84% | — |
| Q1 2024 | 2024-03-31 | −160.69% | −123.50 pp |
| Q4 2023 | 2023-12-31 | −99.35% | −96.20 pp |
| Q3 2023 | 2023-09-30 | −52.99% | −33.61 pp |
| Q2 2023 | 2023-06-30 | −31.76% | −61.71 pp |
| Q1 2023 | 2023-03-31 | −37.19% | −19.64 pp |
| Q4 2022 | 2022-12-31 | −3.16% | −46.17 pp |
| Q3 2022 | 2022-09-30 | −19.38% | — |
| Q2 2022 | 2022-06-30 | 29.96% | — |
| Q1 2022 | 2022-03-31 | −17.55% | — |
| Q4 2021 | 2021-12-31 | 43.01% | — |
Humacyte return on equity trends
Between the periods ended 2022-12-31 and 2023-12-31, Humacyte's return on equity decreased from −10.01% to −169.81%, a change of −159.80 percentage points. The latest reported quarter, Q2 2026, shows −171.63%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Humacyte source filings ↗